Teladoc Health (NYSE:TDOC) Shares Up 6%

Shares of Teladoc Health, Inc. (NYSE:TDOCGet Rating) shot up 6% on Friday . The company traded as high as $35.53 and last traded at $35.21. 14,465 shares traded hands during trading, a decline of 100% from the average session volume of 6,406,522 shares. The stock had previously closed at $33.21.

A number of equities analysts have commented on TDOC shares. Deutsche Bank Aktiengesellschaft reduced their target price on shares of Teladoc Health from $78.00 to $44.00 in a report on Thursday, April 28th. William Blair cut shares of Teladoc Health from an “outperform” rating to a “market perform” rating in a research report on Thursday, April 28th. Robert W. Baird cut their price target on shares of Teladoc Health from $72.00 to $64.00 in a report on Wednesday, April 27th. Guggenheim downgraded Teladoc Health from a “buy” rating to a “neutral” rating in a research report on Thursday, April 28th. Finally, Credit Suisse Group cut Teladoc Health from an “outperform” rating to a “neutral” rating and lowered their price objective for the stock from $114.00 to $35.00 in a research report on Thursday, April 28th. One investment analyst has rated the stock with a sell rating, eighteen have given a hold rating and nine have given a buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $87.00.

The stock has a market cap of $5.60 billion, a PE ratio of -0.82 and a beta of 0.81. The business has a 50 day moving average price of $35.25 and a 200 day moving average price of $60.79. The company has a quick ratio of 3.71, a current ratio of 3.94 and a debt-to-equity ratio of 0.17.

Teladoc Health (NYSE:TDOCGet Rating) last released its quarterly earnings data on Wednesday, April 27th. The health services provider reported ($0.47) EPS for the quarter, topping the consensus estimate of ($0.55) by $0.08. The business had revenue of $565.35 million for the quarter, compared to analyst estimates of $568.91 million. Teladoc Health had a negative return on equity of 2.12% and a negative net margin of 321.94%. During the same quarter in the prior year, the firm posted $0.13 EPS. On average, research analysts predict that Teladoc Health, Inc. will post -2.05 earnings per share for the current fiscal year.

In other Teladoc Health news, CFO Mala Murthy sold 4,053 shares of the stock in a transaction on Monday, June 27th. The shares were sold at an average price of $37.32, for a total transaction of $151,257.96. Following the transaction, the chief financial officer now directly owns 27,295 shares of the company’s stock, valued at $1,018,649.40. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, SVP Daniel Trencher sold 1,000 shares of the business’s stock in a transaction dated Friday, June 17th. The stock was sold at an average price of $29.12, for a total transaction of $29,120.00. Following the sale, the senior vice president now directly owns 28,408 shares of the company’s stock, valued at approximately $827,240.96. The disclosure for this sale can be found here. Corporate insiders own 1.55% of the company’s stock.

A number of large investors have recently bought and sold shares of the business. Future Financial Wealth Managment LLC acquired a new stake in shares of Teladoc Health in the fourth quarter valued at about $29,000. CarsonAllaria Wealth Management Ltd. acquired a new stake in Teladoc Health in the 4th quarter valued at about $30,000. DB Wealth Management Group LLC purchased a new position in Teladoc Health in the 1st quarter worth approximately $25,000. McCarthy Asset Management Inc. purchased a new position in Teladoc Health in the 1st quarter worth approximately $25,000. Finally, Oliver Lagore Vanvalin Investment Group acquired a new position in shares of Teladoc Health during the 1st quarter worth approximately $27,000. Institutional investors own 87.17% of the company’s stock.

About Teladoc Health (NYSE:TDOC)

Teladoc Health, Inc provides virtual healthcare services in the United States and internationally. The company offers a portfolio of services and solutions covering non-urgent, episodic, chronic, and complicated medical conditions, including diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and mental health conditions.

Featured Stories

Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.